Skip to content

Acupuncture for peri-menopause Insomnia: a randomized controlled trial

Acupuncture for peri-menopause Insomnia: a randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007199
Enrollment
Unknown
Registered
2015-10-11
Start date
2015-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peri-menopause Insomnia

Interventions

Control:sham-acupuncture

Sponsors

Yueyang Hospital of Intergrated Traditional Chinese andWestern Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. diagnosis of primary insomnia according to the ICSD-3 criteria for at least 3 months; 2. women in peri-menopause period; 3. total score of Pittsburgh Sleep Quality Index (PSQI) at least 5-point; 4. haven't received any acupuncture treatment.

Exclusion criteria

Exclusion criteria: 1. were taking herbal remedies, over-the-counter medications, or psychotropic drugs that were intended for the treatment of insomnia within the last 2 weeks prior to baseline or during the study; 2. use of hormones or hormonal contraceptives in the past 2 months; 3. were diagnosed to with a concurrent major depressive disorder, generalized anxiety disorder, panic disorder, manic or hypomanic episode, substance use disorder besides caffeine or nicotine use, organic mental disorder, schizophrenia, or any other psychotic disorder based on the Structured Clinical Interview for the DSM-IV (SCID) ; 4. had an apnea-hypopnea index of 10 or greater or a periodic limb movement index with arousal of 15 or greater, as detected during overnight polysomnography; 5. had an infection or abscess close to the site of the selected acupoints; 6. had any serious physical illness; 7. had participated in any clinical trial within the 3 months prior to baseline.

Design outcomes

Primary

MeasureTime frame
PSG;PSQI;ISI;BDI;BAI;FS-14;SF-36;

Countries

China

Contacts

Public ContactChen Yunfei
icyf1968@163.com+86 13917922206

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026